Latest News

In December 2025, MyOme announced a collaboration and investment from Illumina to support its Proactive Health Trial, which will test whole-genome sequencing combined with AI-integrated risk models across common, chronic, and rare diseases, with enrollment expected to start in 2026. This partnership links Illumina’s population-scale sequencing capabilities with MyOme’s AI-driven risk assessment tools, highlighting a push toward earlier, more personalized interventions that aim to cut a very...

NIPPON REIT Investment (TSE:3296) is shaking up its Tokyo portfolio by selling the ageing Kudankita 325 office building and buying the newer CIRCLES Nihonbashi Hamacho, aiming for fresher assets, steadier income and better tax efficiency. See our latest analysis for NIPPON REIT Investment. These portfolio upgrades and boardroom changes come against a backdrop of steady momentum, with a roughly 30 percent year to date share price return and a robust 12 month total shareholder return above 40...

Martin Marietta Materials (MLM) has quietly kept climbing, with shares up about 5% over the past month and nearly 24% this year, as investors focus on steady infrastructure and construction demand. See our latest analysis for Martin Marietta Materials. At around $633.94 a share, that solid year to date share price return of roughly 24% and a three year total shareholder return near 91% suggest investors are steadily pricing in durable infrastructure growth rather than a one quarter story. If...

Anheuser-Busch InBev (ENXTBR:ABI) has investors talking after announcing plans to close its Fairfield and Merrimack breweries and sell its Newark facility, consolidating U.S. production to sharpen efficiency and support higher growth brands. See our latest analysis for Anheuser-Busch InBev. The consolidation news lands after a solid run, with an 11.43% 3 month share price return and a 16.87% one year total shareholder return suggesting momentum is quietly rebuilding around the story. If this...

If you are looking at Venture Global and wondering whether the recent slump has quietly turned it into a value play, you are not alone. The stock has bounced 3.3% over the last week even after a steep 12.4% drop over 30 days and a bruising 73.5% slide year to date. This combination often signals the market is rapidly reassessing both its growth prospects and risk profile. Recent headlines around Venture Global have centered on shifting investor sentiment in the LNG and broader energy space,...

LendingClub (LC) just delivered a stronger quarter, with revenue and net income up solidly from last year, and that combination of earnings momentum and heavy loan demand is starting to reshape how investors view the stock. See our latest analysis for LendingClub. The upbeat quarter lands on top of an already strong run, with a roughly 21.8% year to date share price return and a powerful three year total shareholder return of about 126.6% suggesting momentum is firmly building. If...

If you are wondering whether CME Group is still worth buying after its long run, or if the market has already priced in the upside, you are not alone. That is exactly what we are going to unpack here. The stock has slipped around 1.6% over the last week and 1.5% over the past month, but it is still up 15.6% year to date and 17.8% over the last year, with multi year returns above 78% over three years and 82.2% over five years. Recent market attention has centered on CME as a key beneficiary...

Astellas Pharma (TSE:4503) has quietly outperformed the broader Japanese market over the past year, gaining about 43% as investors warm to its oncology pipeline, steady cash generation, and improving long term return profile. See our latest analysis for Astellas Pharma. That momentum has not come out of nowhere, with a 90 day share price return of 26.7% and a 1 year total shareholder return of about 43% pointing to steadily improving sentiment rather than a brief spike. If Astellas recent run...

The latest joint venture acquisition of the 195,000 square foot Springs Plaza center in Bonita Springs puts Phillips Edison (PECO) back in focus and highlights how it is leaning into high growth, necessity retail markets. See our latest analysis for Phillips Edison. That Springs Plaza deal slots neatly into a year where momentum has been steady rather than spectacular, with a modest positive multi month share price return and a solid three year total shareholder return of 25 percent...

Evolv Technologies Holdings (EVLV) is back in the spotlight after announcing its Evolv Express systems are being installed at the 14,000 seat Pechanga Arena San Diego, further extending its footprint across major California venues. See our latest analysis for Evolv Technologies Holdings. That expanding customer list seems to be feeding into sentiment, with the share price at $7.21 and a strong year to date share price return alongside a robust one year total shareholder return, suggesting...

Amgen (AMGN) just checked two big boxes at once, tightening its partnership with Washington on drug pricing while winning FDA approval for UPLIZNA in generalized myasthenia gravis, and the stock is reacting accordingly. See our latest analysis for Amgen. That backdrop of tariff relief and drug price cooperation, combined with the fresh UPLIZNA approval, comes on top of a strong run, with Amgen’s share price up 26.27% year to date and a 5 year total shareholder return of 71.89%, which suggests...

Celanese (CE) has had a choppy year in the market, with the stock sliding sharply year to date even as revenue edges higher and net income rebounds from a deep loss. Investors are now reassessing what that disconnect really means. See our latest analysis for Celanese. At around $42.29 per share, Celanese’s 11.49% 1 month share price return looks like a short term bounce within a much tougher backdrop. The 5 year total shareholder return is still deeply negative and momentum appears more...

SY Holdings Group (SEHK:6069) just doubled down on its core supply chain finance engine by extending and enlarging guarantees and loans to key affiliates through 2027, a balance sheet commitment big enough to trigger Hong Kong Listing Rules disclosure. See our latest analysis for SY Holdings Group. That backdrop helps explain why investors have largely leaned in this year, with the share price climbing strongly, reflected in a 57.72% year to date share price return and a 64.32% one year total...

Triumph Financial (TFIN) is back in the spotlight after BlueGrace Logistics joined the Triumph Network, a move that tightens Triumph’s grip on fintech powered freight payments and back office automation. See our latest analysis for Triumph Financial. The BlueGrace deal comes as Triumph’s 30 day share price return of 15.91% and 90 day share price return of 12.26% clash with a much weaker year to date share price return of minus 30.07%. However, the three year total shareholder return of 25.55%...

Earlier in December 2025, Azenta, Inc. announced a US$250,000,000 share repurchase program running through 2028 and, at its Investor Day, outlined plans to deploy its balance sheet toward disciplined M&A focused on high-margin, recurring-revenue life sciences assets. Management highlighted a funnel of about 60 potential acquisition targets and emphasized strict financial filters, including margin accretion, double-digit ROIC within three to five years, and a bias toward tuck-in deals in...

Ricoh Company (TSE:7752) has given investors a fresh talking point by pairing its third straight top five SCN AV integrator ranking with the launch of the creatively geared GR IV HDF camera. See our latest analysis for Ricoh Company. Despite the buzz around AV integration wins and the GR IV HDF launch, Ricoh’s latest share price of ¥1,365 comes after a weak year to date share price return of around minus 21 percent, even though its five year total shareholder return of roughly 131 percent...

Earlier in December 2025, the U.S. FDA issued a warning letter to Target after recalled ByHeart Whole Nutrition Infant Formula linked to an infant botulism outbreak remained on sale in multiple Target stores across 20 states despite recall notices. The letter highlights not just product safety concerns but also serious weaknesses in Target’s recall execution and regulatory communications, raising questions about its internal controls for high-risk consumer goods. We’ll now examine how this...

Kimberly-Clark (KMB) has been sliding lately, with the stock down about 4% over the past month and almost 19% in the past 3 months, even as earnings and revenue continue to grow. See our latest analysis for Kimberly-Clark. That slide comes after a tougher stretch for Kimberly-Clark, with the share price returning about negative 23 percent year to date and total shareholder return down roughly 20 percent over the past year. This suggests momentum has clearly faded despite improving...

In recent weeks, XPEL outlined an ambitious US$75–US$150 million capital expenditure plan over the next two years while insiders increased their shareholdings, and an analyst cited potential margin gains as reinforcing the company’s operational strength. This combination of growth investment, insider buying, and confidence in profitability sends a strong signal about how management views XPEL’s long‑term positioning in the paint protection and automotive personalization market. We’ll now...

Fujitsu (TSE:6702) just kicked off its "Fujitsu Accelerator Program for Sports," a push to blend sports and technology in ways that could open fresh revenue streams and reinforce its broader digital services strategy. See our latest analysis for Fujitsu. That push into sports tech lands against a backdrop of strong momentum, with a roughly 55% year to date share price return and a near 55% one year total shareholder return, signalling investors are steadily warming to Fujitsu’s growth...

In recent weeks, Li Auto has faced its first quarterly loss after 11 profitable quarters, hit by a recall of its MEGA model, weaker sales and margins, and analyst downgrades, even as it gained approval to test Level 3 autonomous driving in Beijing. At the same time, Li Auto has accelerated its overseas push into Egypt, Kazakhstan, and Azerbaijan and opened new global AI R&D hubs, signaling a bid to offset domestic pressure with international growth and smarter driving technology. We’ll now...

Earlier this month, EMASS announced a collaboration with Semtech to integrate Semtech’s LoRa transceivers into EMASS’s ECS-DoT low-power edge AI SoCs, enabling long-range, battery-efficient intelligence for industrial, IoT, and security applications and showcasing multiple real-world reference designs at CES 2026 venues including Semtech’s and the LoRa Alliance’s locations. This partnership reinforces Semtech’s push to pair its LoRaWAN connectivity with edge AI processing, aiming to reduce...

Earlier this month, Stewart Information Services completed a follow-on equity offering of 1,900,000 common shares at US$68, raising about US$129.2 million, while also filing an omnibus shelf registration covering common and preferred stock, warrants, units, debt securities and purchase contracts. This combination of fresh equity capital and expanded financing flexibility could meaningfully influence investor views on dilution, balance sheet strength and future funding options. Next, we’ll...

Live Nation Entertainment (LYV) is deepening its footprint in Asia by taking over operations at Bangkok's Impact Arena, pairing venue upgrades with a push for more shows, brand partnerships, and higher quality fan experiences. See our latest analysis for Live Nation Entertainment. That Asia push comes as Live Nation’s share price sits at $141.1, with a solid 1 month share price return of just over 8 percent but a weaker 3 month stretch, while its roughly 100 percent 3 year total shareholder...